These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 22405948)

  • 41. Discussion of improving patient safety and uniformity of care by a standard regimen for the use of oxytocin.
    Sandmire HF; De Mott RK
    Am J Obstet Gynecol; 2009 Mar; 200(3):e10; author reply e10. PubMed ID: 19070832
    [No Abstract]   [Full Text] [Related]  

  • 42. If I were the baby. Questioning the widespread use of synthetic oxytocin.
    Odent M
    Midwifery Today Int Midwife; 2010; (94):22-3. PubMed ID: 20572615
    [No Abstract]   [Full Text] [Related]  

  • 43. A randomized trial comparing vaginal misoprostol versus Foley catheter with concurrent oxytocin for labor induction in nulliparous women.
    Culver J; Strauss RA; Brody S; Dorman K; Timlin S; McMahon MJ
    Am J Perinatol; 2004 Apr; 21(3):139-46. PubMed ID: 15085496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
    Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
    J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Combined use of proserine and oxytocin for the stimulation of labor].
    Strukov VA
    Akush Ginekol (Mosk); 1969 Jan; 45(1):37-40. PubMed ID: 5767818
    [No Abstract]   [Full Text] [Related]  

  • 46. Induction of labor with vaginal prostaglandin E2.
    Yogev Y; Ben-Haroush A; Gilboa Y; Chen R; Kaplan B; Hod M
    J Matern Fetal Neonatal Med; 2003 Jul; 14(1):30-4. PubMed ID: 14563089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is induced labour in the nullipara associated with more maternal and perinatal morbidity?
    Selo-Ojeme D; Rogers C; Mohanty A; Zaidi N; Villar R; Shangaris P
    Arch Gynecol Obstet; 2011 Aug; 284(2):337-41. PubMed ID: 20838800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
    Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prospective study of intramuscular ergometrine compared with intramuscular oxytocin for prevention of postpartum hemorrhage.
    Saito K; Haruki A; Ishikawa H; Takahashi T; Nagase H; Koyama M; Endo M; Hirahara F
    J Obstet Gynaecol Res; 2007 Jun; 33(3):254-8. PubMed ID: 17578351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Labor induction in women with an unfavorable Bishop score: randomized controlled trial of intrauterine Foley catheter with concurrent oxytocin infusion versus Foley catheter with extra-amniotic saline infusion with concurrent oxytocin infusion.
    Guinn DA; Davies JK; Jones RO; Sullivan L; Wolf D
    Am J Obstet Gynecol; 2004 Jul; 191(1):225-9. PubMed ID: 15295370
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of methylergometrine and oxytocin on thoracic epidural pressure during cesarean section.
    Kikutani T; Shimada Y
    J Obstet Gynaecol Res; 2003 Jun; 29(3):180-5. PubMed ID: 12841703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving patient safety and uniformity of care by a standardized regimen for the use of oxytocin.
    Hayes EJ; Weinstein L
    Am J Obstet Gynecol; 2008 Jun; 198(6):622.e1-7. PubMed ID: 18355786
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section.
    Eftekhari N; Doroodian M; Lashkarizadeh R
    J Obstet Gynaecol; 2009 Oct; 29(7):633-6. PubMed ID: 19757270
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computerized physician order entry reduces medication turnaround time of labor induction agents.
    Refuerzo JS; Straub H; Murphy R; Salter L; Ramin SM; Blackwell SC
    Am J Perinatol; 2011 Apr; 28(4):253-8. PubMed ID: 21082536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discontinuation of oxytocin in the active phase of labor.
    Girard B; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M
    Acta Obstet Gynecol Scand; 2009; 88(2):172-7. PubMed ID: 19169930
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
    Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
    Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour--a randomised controlled trial.
    Dencker A; Berg M; Bergqvist L; Ladfors L; Thorsén LS; Lilja H
    BJOG; 2009 Mar; 116(4):530-6. PubMed ID: 19250364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxytocin regimen for labor augmentation, labor progression, and perinatal outcomes.
    Ferrazzi E; Paganelli A; Ragusa A
    Obstet Gynecol; 2012 Feb; 119(2 Pt 1):380-1; author reply 381-2. PubMed ID: 22270295
    [No Abstract]   [Full Text] [Related]  

  • 59. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Oxytocin and syndrome of inappropriate secretion of antidiuretic neonatal hormone. Case report of early severe hyponatremia and literature review].
    Aldana-Valenzuela C; Prieto-Pantoja JA; Hernández-Acevedo A
    Ginecol Obstet Mex; 2010 Dec; 78(12):692-6. PubMed ID: 21961376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.